We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+8.95%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.06B
AUM Growth
+$107M
Cap. Flow
-$28.6M
Cap. Flow %
-1.39%
Top 10 Hldgs %
29.47%
Holding
2,720
New
413
Increased
568
Reduced
616
Closed
259

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$25.8M
2
BND icon
Vanguard Total Bond Market
BND
+$15M
3
LIN icon
Linde
LIN
+$7.79M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$6.97M
5
MDT icon
Medtronic
MDT
+$4.99M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$16.1M
2
AAPL icon
Apple
AAPL
+$3.64M
3
MSFT icon
Microsoft
MSFT
+$2.79M
4
AMZN icon
Amazon
AMZN
+$1.11M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$937K

Sector Composition

Rank Sector Weight
1 Technology 24.3%
2 Healthcare 11.82%
3 Financials 10.45%
4 Consumer Discretionary 9.39%
5 Industrials 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TVRD
2426
Tvardi Therapeutics
TVRD
$22.4M
$7.05K ﹤0.01%
69
+34
+97% +$4.68K
CUE icon
2427
Cue Biopharma
CUE
$112M
$7K ﹤0.01%
+64
New +$7.52K
PIII icon
2428
P3 Health Partners
PIII
$37.6M
$6.96K ﹤0.01%
+47
New +$6.5K
SKYT
2429
DELISTED
SkyWater Technology
SKYT
$6.89K ﹤0.01%
732
– –
KLXE icon
2430
KLX Energy Services
KLXE
$34.2M
$6.85K ﹤0.01%
+704
New +$6.93K
LBPH
2431
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$6.8K ﹤0.01%
+926
New +$7.01K
VOR icon
2432
Vor Biopharma
VOR
$1.37B
$6.79K ﹤0.01%
+110
New +$10K
BTAI icon
2433
BioXcel Therapeutics
BTAI
$34.3M
$6.76K ﹤0.01%
63
– –
LE icon
2434
Lands' End
LE
$405M
$6.74K ﹤0.01%
868
– –
PLX icon
2435
Protalix BioTherapeutics
PLX
$202M
$6.71K ﹤0.01%
+3,354
New +$7.99K
VRCA icon
2436
Verrica Pharmaceuticals
VRCA
$91.9M
$6.69K ﹤0.01%
+116
New +$7.04K
KRMD icon
2437
KORU Medical Systems
KRMD
$157M
$6.69K ﹤0.01%
+1,939
New +$7.61K
PSTX
2438
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$6.62K ﹤0.01%
+3,763
New +$9.61K
ILPT
2439
Industrial Logistics Properties Trust
ILPT
$616M
$6.61K ﹤0.01%
2,002
-3,592
-64% -$8.01K
HRTX icon
2440
Heron Therapeutics
HRTX
$67.5M
$6.6K ﹤0.01%
5,693
+2,667
+88% +$4.76K
NVCT icon
2441
Nuvectis Pharma
NVCT
$634M
$6.56K ﹤0.01%
+411
New +$6.56K
RBOT
2442
DELISTED
Vicarious Surgical
RBOT
$6.32K ﹤0.01%
115
– –
WLFC icon
2443
Willis Lease Finance
WLFC
$1.18B
$6.1K ﹤0.01%
+468
New +$7.24K
XAIR icon
2444
Beyond Air
XAIR
$5.23M
$6.04K ﹤0.01%
+4
New +$9.14K
KLRS
2445
Kalaris Therapeutics
KLRS
$92.4M
$5.92K ﹤0.01%
76
+56
+280% +$5.32K
NGM
2446
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$5.82K ﹤0.01%
2,246
– –
WHWK
2447
Whitehawk Therapeutics
WHWK
$270M
$5.55K ﹤0.01%
+812
New +$6.31K
HPK icon
2448
HighPeak Energy
HPK
$890M
$5.38K ﹤0.01%
494
– –
FSP
2449
Franklin Street Properties
FSP
$48.1M
$4.07K ﹤0.01%
2,806
-5,471
-66% -$7.57K
NKTX icon
2450
Nkarta
NKTX
$171M
$4K ﹤0.01%
1,827
+1,619
+778% +$7.12K
96 97
98
99 100

Similar funds

GWM
Graybill Wealth Management Elmhurst, Illinois $328M AUM 21.42% 1-Year Est. Return
KSCM
King Street Capital Management New York $328M AUM 0.61% 1-Year Est. Return
AFS
Aft Forsyth & Sober Valrico, Florida $328M AUM 25.24% 1-Year Est. Return
BAM
Blueshift Asset Management Red Bank, New Jersey $330M AUM 7.9% 1-Year Est. Return
ML
Maniro Ltd Nassau $330M AUM
ISFAN
Investor's Fiduciary Advisor Network Snoqualmie, Washington $326M AUM 19.7% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return
ECH
ER Collective Holdings Washington, District of Columbia $326M AUM

Metropolitan Life Insurance Company (MetLife)'s Q2 2023 Portfolio in Review

As of Q2 2023, Metropolitan Life Insurance Company (MetLife) held 2,720 positions worth $2.06B, up 5.5% from $1.95B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q2 2023 filing shows 413 new, 568 increased, 616 reduced and 259 closed positions. Its largest new stake was Alphabet (Google) Class C: 222,708 shares worth $26.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $16.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2023 buy was Alphabet (Google) Class C: 222,708 shares worth $26.9M.
  • Metropolitan Life Insurance Company (MetLife) added most to Vanguard Total Bond Market in Q2 2023, an estimated $15M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $16.1M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Iridium Communications in Q2 2023, selling an estimated $418K.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 29% of its $2.06B portfolio in Q2 2023.
  • Metropolitan Life Insurance Company (MetLife) opened 413 new positions and closed 259 in Q2 2023.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 5.5% quarter-over-quarter to $2.06B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.